Se. Akopov, NITRIC-OXIDE (EDRF) ENHANCES THE VASORELAXING EFFECT OF DIHYDROPYRIDINE CALCIUM-ANTAGONISTS IN ISOLATED HUMAN MIDDLE CEREBRAL-ARTERIES, Methods and findings in experimental and clinical pharmacology, 18(2), 1996, pp. 101-104
Experiments were performed on perfused human middle cerebral artery (M
CA) precontracted with prostaglandin F2(alpha). Nifedipine, isradipine
and lacidipine induced dose-dependent relaxant effects on MCA segment
s. Effects of nifedipine were rather similar on MCA segments with and
without endothelium; however, responses of endothelium-denuded vessel
segments to isradipine and especially lacidipine were lower than those
of vessels with the intact endothelium. The vasodilator effects of th
ese agents, especially isradipine and lacidipine, on vessel segments w
ith intact endothelium in the presence of a NO-synthase inhibitor, N-n
itro-L-arginine, were significantly attenuated whereas a cycloxygenase
inhibitor, indomethacin, did not significantly alter vasodilator resp
onses of MCA segments to all calcium antagonists tested. It is suggest
ed that the endothelium modulates vascular relaxation to dihydropyridi
nes by an enhancement of calcium antagonist actions by basally release
d EDRF/NO at the level of vascular smooth muscles or by a dihydropyrid
ine-induced increase in the release of EDRF/No.